PulteGroup Overview
Valuation check: PHM's ROE is 14649.5%, above the Healthcare sector average of 21.3%.
Get informed when a big investor buys or sells
+ Follow14649.50%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
PulteGroup (PHM) currently reports a ROE of 14649.5%. That is above the Healthcare sector average of 21.3%. Use the charts on this page to explore PulteGroup's ROE history and peer comparisons.
PulteGroup's ROE of 14649.5% is higher than the Healthcare sector average of 21.3%. That is roughly 68668.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but PulteGroup's current 14649.5% should be judged against Healthcare norms (sector average: 21.3%) and against PHM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 14649.5%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.3%. From there, open related valuation or income-statement pages for PulteGroup, and consider following PHM for alerts when major investors trade the stock.
PulteGroup is classified in the Healthcare sector. On ROE, it currently shows 14649.5% versus a sector average near 21.3%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHM with unrelated industries.
